FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372648004: Atypical antipsychotic (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197942011 Atypical antipsychotic (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211175015 Atypical antipsychotic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1197942011 Atypical antipsychotic (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1197942011 Atypical antipsychotic (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1211175015 Atypical antipsychotic en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1211175015 Atypical antipsychotic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Atypical antipsychotic Is a Anti-psychotic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Quetiapine fumarate Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Norclozapine Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Quetiapine (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing sertindole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 5mg dispersible tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 10 mg orodispersible tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Quetiapine 25mg+100mg+150mg tablet starter pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely quetiapine 150 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Atypical antipsychotic The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 15mg disintergrating tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 20 mg orodispersible tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine oral disintergrating tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Clozapine (substance) Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Amisulpride - chemical (substance) Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Zotepine Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 30 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing fluoxetine and olanzapine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Olanzapine 10mg powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Ziprasidone (substance) Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Quetiapine (as quetiapine fumarate) 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely quetiapine (as quetiapine fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Quetiapine fumarate 300mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing remoxipride (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 1 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Remoxipride hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Sertindole Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Aripiprazole 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Asenapine (substance) Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Lurasidone (substance) Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)
    Pimavanserin (substance) Is a False Atypical antipsychotic Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start